| [1] |
VIMPERE L, SAMI J, JEANNOT E. Cervical cancer screening programs for female sex workers: a scoping review[J]. Front Public Health, 2023, 11: 1226779.
|
| [2] |
BAI Y Y, WANG W H, CHENG Y M, et al. Research progress on the GRP78 gene in the diagnosis, treatment and immunity of cervical cancer[J]. Eur J Med Res, 2023, 28(1): 447.
|
| [3] |
SMALL W Jr, BACON M A, BAJAJ A, et al. Cervical cancer: a global health crisis[J]. Cancer, 2017, 123(13): 2404-2412.
|
| [4] |
GADDUCCI A, COSIO S. Pharmacological treatment of patients with metastatic, recurrent or persistent cervical cancer not amenable by surgery or radiotherapy: state of art and perspectives of clinical research[J]. Cancers, 2020, 12(9): 2678.
|
| [5] |
SANTORO A, ANGELICO G, INZANI F, et al. The emerging and challenging role of PD-L1 in patients with gynecological cancers: an updating review with clinico-pathological considerations[J]. Gynecol Oncol, 2024, 184: 57-66.
|
| [6] |
BHATTACHARJEE R, DAS S S, BISWAL S S, et al. Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies[J]. Crit Rev Oncol, 2022, 174: 103675.
|
| [7] |
ZHAO F H, LANG J H, QIAO Y L, et al. How can China achieve WHO’s 2030 targets for eliminating cervical cancer?[J]. BMJ, 2024, 386: e078641.
|
| [8] |
ZHAO Q Q, YANG S B, HAO S J, et al. Identification of transcriptionally-active human papillomavirus integrants through nanopore sequencing reveals viable targets for gene therapy against cervical cancer[J]. J Med Virol, 2024, 96(6): e29769.
|
| [9] |
ZHANG D M, ZHAO M Q, JIANG P, et al. RPL22L1 fosters malignant features of cervical cancer via the modulation of DUSP6-ERK axis[J]. J Transl Med, 2025, 23(1): 244.
|
| [10] |
WU Q, JIN Y H, LI S, et al. Oncolytic Newcastle disease virus carrying the IL24 gene exerts antitumor effects by inhibiting tumor growth and vascular sprouting[J]. Int Immunopharmacol, 2024, 136: 112305.
|
| [11] |
DENG L L, FAN J, DING Y D, et al. Target therapy with vaccinia virus harboring IL-24 for human breast cancer[J]. J Cancer, 2020, 11(5): 1017-1026.
|
| [12] |
QURESHI S, AHMED N, REHMAN H M, et al. Investigation of therapeutic potential of the IL-24-p20 fusion protein against breast cancer: an in-silico approach[J]. In Silico Pharmacol, 2024, 12(2): 84.
|
| [13] |
SCRIVO R, CONIGLIARO P, RICCIERI V, et al. Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation[J]. Clin Exp Immunol, 2015, 179(2): 300-308.
|
| [14] |
ZHONG Y J, ZHANG X, CHONG W P. Interleukin-24 immunobiology and its roles in inflammatory diseases[J]. Int J Mol Sci, 2022, 23(2): 627.
|
| [15] |
ZHANG K, HU W H, LI F, et al. IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells[J]. Br J Cancer, 2024, 130(8): 1337-1347.
|
| [16] |
CHEN J T, ZHANG Y W, ZHANG H, et al. IL-24 is the key effector of Th9 cell-mediated tumor immunotherapy[J]. iScience, 2023, 26(9): 107531.
|
| [17] |
SAHASRABUDDHE V V. Cervical cancer: precursors and prevention[J]. Hematol Oncol Clin North Am, 2024, 38(4): 771-781.
|
| [18] |
TRIPATHI T, YADAV J, JANJUA D, et al. Targeting cervical cancer stem cells by phytochemicals[J]. Curr Med Chem, 2024, 31(32): 5222-5254.
|
| [19] |
BOSCH F X, LORINCZ A, MUÑOZ N, et al. The causal relation between human papillomavirus and cervical cancer[J]. J Clin Pathol, 2002, 55(4): 244-265.
|
| [20] |
HU C C, LIU T Y, HAN C Y, et al. HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m6A-MYC expression[J]. Int J Biol Sci, 2022, 18(2): 507-521.
|
| [21] |
PI R J, LI T Y, ZHANG H, et al. The distribution of HR-HPV E6/E7 DNA and mRNA by histological grade and the clinical performance for detection of cervical cancer and precancer[J]. J Med Virol, 2024, 96(11): e70026.
|
| [22] |
GUPTA P, SU Z Z, LEBEDEVA I V, et al. Mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine[J]. Pharmacol Ther, 2006, 111(3): 596-628.
|
| [23] |
YU H, LIN L B, ZHANG Z Q, et al. Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study[J]. Sig Transduct Target Ther, 2020, 5(1): 209.
|
| [24] |
GU N J, WU M Z, HE L, et al. HPV 16 E6/E7 up-regulate the expression of both HIF-1α and GLUT1 by inhibition of RRAD and activation of NF-κB in lung cancer cells[J]. J Cancer, 2019, 10(27): 6903-6909.
|
| [25] |
HUSSAIN I, FATHALLAH I, ACCARDI R, et al. NF-kappaB protects human papillomavirus type 38 E6/E7-immortalized human keratinocytes against tumor necrosis factor alpha and UV-mediated apoptosis[J]. J Virol, 2011, 85(17): 9013-9022.
|